IONS vs TREE · rev $226.6M vs P/E 2.8, rev $900.2M
Ionis Pharmaceuticals Inc (IONS) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
IONS currently screens at market cap $12.28B. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the IONS and TREE stock pages for the full models.
Not investment advice.